감염 감시 솔루션 : 시장 점유율 분석, 산업 동향, 통계, 성장 예측(2025-2030년)

The infection surveillance solutions market size stands at USD 0.91 billion in 2025 and is projected to reach USD 1.69 billion by 2030, delivering a 13.2% CAGR as healthcare providers institutionalize digital infection-control workflows learned during the pandemic.

Expansion is propelled by new U.S. and EU rules obligating electronic submission of healthcare-associated infection (HAI) data, tighter value-based reimbursement, and rapid uptake of AI-based early-warning algorithms that cut sepsis detection times. Hospitals accelerate spending to avoid CMS penalties tied to respiratory illness reporting, while smaller facilities gravitate toward cloud subscriptions that trim capital budgets despite lingering cybersecurity fears following the 2024 Change Healthcare breach. Vendors differentiate on interoperability with EHRs, HL7-FHIR readiness, and embedded predictive analytics, and most are layering managed services on top of core software to relieve staffing constraints. Overall, the infection surveillance solutions market benefits from a convergence of regulation, economics, and technology that turns digital surveillance from a "nice-to-have" into mandatory clinical infrastructure.

Global Infection Surveillance Solutions Market Trends and Insights

Rising Incidence of HAIs and Stringent Regulation

Healthcare-associated infections cost U.S. hospitals USD 25-45 billion a year, making surveillance investment an economic imperative. CMS finalized fresh quality measures for catheter-associated UTIs and central-line infections in its FY 2025 rule set, and the European Health Data Space will require standardized infection reporting across 27 member states by 2029. German facilities illustrate the payoff: preventing a single nosocomial episode can avoid 12 added bed-days and generate EUR 390-650 in incremental revenue. As penalties tighten, the infection surveillance solutions market becomes non-discretionary infrastructure.

Government Penalties and Reimbursement Reforms

CMS's Hospital-Acquired Condition Reduction Program imposes 1% payment cuts on the worst-performing quartile of hospitals, linking revenue directly to infection metrics. New participation rules effective November 2024 extend mandatory weekly respiratory-illness uploads, forcing institutions to automate reporting or forfeit Medicare dollars. Parallel frameworks in Japan attach reimbursement uplifts to certified EHR and surveillance connectivity. The penalty-or-pay dynamic generates predictable demand for infection surveillance solutions market deployments across acute and post-acute settings.

High Up-Front Costs for Smaller Facilities

Basic EMR deployments still demand USD 13,100 per provider and full-featured surveillance can add USD 50,000 annually-tough numbers for rural hospitals. Nonetheless, five-year net benefits reach USD 86,400 via avoided HAIs and charge capture. Pending U.S. legislation aims to subsidize rural adoption, while cloud Software-as-a-Service offerings align spend with usage, easing entry into the infection surveillance solutions market.

Other drivers and restraints analyzed in the detailed report include:

1. Rapid EHR Adoption Enabling Seamless Data Feeds
2. Migration to Cloud-Based Surveillance Platforms
3. Clinical Workflow Resistance to New IT Systems

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Surgical-site infections contributed USD 0.47 billion in 2024, representing the largest slice of the infection surveillance solutions market. CMS penalty structures and public reporting keep surgical metrics in executive dashboards, sustaining investment in perioperative surveillance modules. AI-augmented image and vital-sign analyzers now flag wound deterioration within hours, enhancing compliance and trimming readmission risks. In contrast, blood-stream infections generated a smaller base but clock the highest 13.8% CAGR thanks to continuous physiological data streams that feed machine-learning sepsis predictors. The infection surveillance solutions market size for blood-stream monitoring is projected to hit USD 0.41 billion by 2030 as validation studies prove 26% mortality reduction. Other categories such as catheter-associated UTIs and ventilator-associated pneumonia benefit from device usage audits and bedside dashboards that push adherence reminders in real time.

Clinical priority differences steer vendor road maps. Surgical-site modules emphasize operating-room scheduling links and antimicrobial prophylaxis timers, while blood-stream modules pivot around real-time lab cultures and antibiotic stewardship tools. Emerging whole-genome sequencing tie-ins will likely blur boundaries, enabling unified dashboards that overlay pathogen lineage on infection type. Still, hospitals are expected to license separate analytic bundles through 2030, ensuring the infection surveillance solutions market continues to generate type-specific revenue streams.

Software platforms delivered 67.8% of overall revenue in 2024 and continue to anchor most RFPs due to health systems' preference for integrated EHR plug-ins. Market leaders invest in low-code configurations so infection-control teams can tweak alert thresholds without programmer support. Yet services revenue rises at a faster 14.7% clip as facilities outsource rule tuning, report generation, and AI model retraining. Managed-service providers package 24/7 monitoring, regulatory updates, and analytics talent, appealing to resource-strained safety-net hospitals. As a result, the infection surveillance solutions market size attributable to services may near USD 0.62 billion by 2030, blurring the classic product-versus-services distinction.

Vendor strategies increasingly bundle outcome-based contracts in which monthly fees flex with performance on HAI benchmarks. That shift moves risk off hospital balance sheets while guaranteeing recurring revenue for suppliers. Expect further migration toward platform-plus-service subscriptions, solidifying long-tail value capture across the infection surveillance solutions market.

The Infection Surveillance Solutions Market Report is Segmented by Type (Surgical-Site Infections, Blood-Stream Infections, Catheter-Associated UTIs, and Ventilator-Associated Pneumonia), Offering (Software and Services), Deployment Model (On-Premise and Cloud), End User (Hospitals, Long-Term Care Facilities, Ambulatory Surgery Centers, and More), and Geography. The Market Forecasts are Provided in Terms of Value (USD).

Geography Analysis

North America generated 38.1% of 2024 revenue, underpinned by mandatory NHSN reporting and CMS reimbursement levers that compel every acute-care facility to maintain certified electronic surveillance. Federal rules effective November 2024 now require hospitals to upload weekly COVID-19, influenza, and RSV counts, cementing demand for automated platforms. High-profile AI pilots across leading U.S. IDNs stimulate peer adoption and validate ROI calculations for budget committees.

Asia-Pacific records the highest 13.5% CAGR through 2030 as Japan, China, and South Korea leapfrog legacy architectures with cloud-native deployments. Japan's super-aged demographics amplify the value proposition for labor-saving surveillance, while China's top-down digitization funds EHR nodes even in tier-2 cities. Private equity flows into telehealth and hospital-at-home models further expand the infection surveillance solutions market because remote-care workflows still require infection-risk oversight.

Europe advances steadily on the back of the European Health Data Space. EHDS mandates interoperable EHRs and cross-border infection reporting by 2029, a deadline accelerating procurement cycles. Strict GDPR rules elevate demand for platforms with embedded anonymization and secure-processing zones, and wastewater-plus-genomic pilots across 10 EU nations showcase the region's integrated, multi-modal approach to pathogen monitoring.

1. Becton, Dickinson and Company
2. Cerner Corporation
3. Wolters Kluwer N.V. (Sentri7)
4. Premier Inc. (Theradoc)
5. IBM Corporation (Truven)
6. VigiLanz Corporation
7. Epic Systems Corporation
8. RL Datix Ltd
9. Baxter International Inc. (ICNet)
10. Gojo Industries Inc.
11. Ecolab Inc.
12. Ocean Health Systems (Multiprac)
13. Inovalon (VigiLanz)
14. PINC AI
15. Meditech Surveillance
16. SafetySpect
17. PDI Healthcare
18. 6sense (BioFire Link)

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising incidence of HAIs and stringent regulation
  • 4.2.2 Government penalties and reimbursement reforms
  • 4.2.3 Rapid EHR adoption enabling seamless data feeds
  • 4.2.4 Migration to cloud-based surveillance platforms
  • 4.2.5 AI-driven predictive analytics for antimicrobial stewardship
  • 4.2.6 Real-time syndromic surveillance against emerging pathogens
• 4.3 Market Restraints
  • 4.3.1 High up-front costs for smaller facilities
  • 4.3.2 Clinical workflow resistance to new IT systems
  • 4.3.3 Interoperability gaps across disparate data standards
  • 4.3.4 Heightened cyber-security and privacy concerns for cloud
• 4.4 Value Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Bargaining Power of Suppliers
  • 4.7.2 Bargaining Power of Consumers
  • 4.7.3 Threat of New Entrants
  • 4.7.4 Threat of Substitute Products
  • 4.7.5 Intensity of Competitive Rivalry
• 4.8 Assessment of the Impact of Macroeconomic Trends on the Market

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)

• 5.1 By Type
  • 5.1.1 Surgical-Site Infections
  • 5.1.2 Blood-Stream Infections
  • 5.1.3 Catheter-Associated UTIs
  • 5.1.4 Ventilator-Associated Pneumonia
• 5.2 By Offering
  • 5.2.1 Software
  • 5.2.2 Services
• 5.3 By Deployment Model
  • 5.3.1 On-Premise
  • 5.3.2 Cloud
• 5.4 By End User
  • 5.4.1 Hospitals
  • 5.4.2 Long-term Care Facilities
  • 5.4.3 Ambulatory Surgery Centers
  • 5.4.4 Public-Health and Reference Labs
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 South Korea
    • 5.5.3.5 Australia
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 South America
    • 5.5.4.1 Brazil
    • 5.5.4.2 Argentina
    • 5.5.4.3 Rest of South America
  • 5.5.5 Middle East and Africa
    • 5.5.5.1 Middle East
    • 5.5.5.1.1 Saudi Arabia
    • 5.5.5.1.2 United Arab Emirates
    • 5.5.5.1.3 Turkey
    • 5.5.5.1.4 Rest of Middle East
    • 5.5.5.2 Africa
    • 5.5.5.2.1 South Africa
    • 5.5.5.2.2 Egypt
    • 5.5.5.2.3 Nigeria
    • 5.5.5.2.4 Rest of Africa

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Share Analysis
• 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.4.1 Becton, Dickinson and Company
  • 6.4.2 Cerner Corporation
  • 6.4.3 Wolters Kluwer N.V. (Sentri7)
  • 6.4.4 Premier Inc. (Theradoc)
  • 6.4.5 IBM Corporation (Truven)
  • 6.4.6 VigiLanz Corporation
  • 6.4.7 Epic Systems Corporation
  • 6.4.8 RL Datix Ltd
  • 6.4.9 Baxter International Inc. (ICNet)
  • 6.4.10 Gojo Industries Inc.
  • 6.4.11 Ecolab Inc.
  • 6.4.12 Ocean Health Systems (Multiprac)
  • 6.4.13 Inovalon (VigiLanz)
  • 6.4.14 PINC AI
  • 6.4.15 Meditech Surveillance
  • 6.4.16 SafetySpect
  • 6.4.17 PDI Healthcare
  • 6.4.18 6sense (BioFire Link)

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

• 7.1 White-space and Unmet-need Assessment